Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 84 articles:
HTML format
Text format



Single Articles


    February 2019
  1. VISA A, Sallan MC, Maiques O, Alza L, et al
    T-type Cav3.1 channels mediate progression and chemotherapeutic resistance in glioblastoma.
    Cancer Res. 2019 Feb 12. pii: 0008-5472.CAN-18-1924.
    PubMed     Text format     Abstract available


  2. MASTRELLA G, Hou M, Li M, Stoecklein VM, et al
    Targeting APLN/APLNR improves anti-angiogenic efficiency and blunts pro-invasive side effects of VEGFA/VEGFR2-blockade in glioblastoma.
    Cancer Res. 2019 Feb 4. pii: 0008-5472.CAN-18-0881.
    PubMed     Text format     Abstract available


  3. ATKINS I, Kinnersley B, Ostrom QT, Labreche K, et al
    Transcriptome-wide association study identifies new candidate susceptibility genes for glioma.
    Cancer Res. 2019 Feb 1. pii: 0008-5472.CAN-18-2888.
    PubMed     Text format     Abstract available


    January 2019
  4. PARK HK, Hong JH, Oh YT, Kim SS, et al
    Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells.
    Cancer Res. 2019 Jan 25. pii: 0008-5472.CAN-18-2558.
    PubMed     Text format     Abstract available


  5. DORON H, Pukrop T, Erez N
    A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis.
    Cancer Res. 2019 Jan 24. pii: 0008-5472.CAN-18-1805.
    PubMed     Text format     Abstract available


  6. GOBIN M, Nazarov PV, Warta R, Timmer M, et al
    A DNA repair and cell cycle gene expression signature in primary and recurrent glioblastoma: prognostic value and clinical implications.
    Cancer Res. 2019 Jan 23. pii: 0008-5472.CAN-18-2076.
    PubMed     Text format     Abstract available


  7. SUN T, Patil R, Galstyan A, Klymyshyn D, et al
    Blockade of a laminin-411 - Notch axis with CRISPR/Cas9 or a nanobioconjugate inhibits glioblastoma growth through tumor-microenvironment crosstalk.
    Cancer Res. 2019 Jan 18. pii: 0008-5472.CAN-18-2725.
    PubMed     Text format     Abstract available


    November 2018
  8. MORGAN MA, Canman CE
    Replication Stress: An Achilles' Heel of Glioma Cancer Stem-like Cells.
    Cancer Res. 2018 Nov 29. pii: 0008-5472.CAN-18-2439.
    PubMed     Text format     Abstract available


  9. MA L, Lin K, Chang G, Chen Y, et al
    Aberrant activation of beta-catenin signaling drives glioma tumorigenesis via USP1-mediated stabilization of EZH2.
    Cancer Res. 2018 Nov 13. pii: 0008-5472.CAN-18-1304.
    PubMed     Text format     Abstract available


  10. AN Z, Knobbe-Thomsen CB, Wan X, Fan QW, et al
    EGFR cooperates with EGFRvIII to recruit macrophages in glioblastoma.
    Cancer Res. 2018 Nov 6. pii: 0008-5472.CAN-17-3551.
    PubMed     Text format     Abstract available


  11. MAIR R, Mouliere F, Smith CG, Chandrananda D, et al
    Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models.
    Cancer Res. 2018 Nov 2. pii: 0008-5472.CAN-18-0074.
    PubMed     Text format     Abstract available


    October 2018
  12. AASLAND D, Gotzinger L, Hauck L, Berte N, et al
    Temozolomide induces senescence and repression of DNA repair pathways in glioblastoma cells via activation of ATR-CHK1, p21, and NF-kB.
    Cancer Res. 2018 Oct 25. pii: 0008-5472.CAN-18-1733.
    PubMed     Text format     Abstract available


  13. ALMIRON BONNIN DA, Havrda MC, Israel MA
    Glioma Cell Secretion: A Driver of Tumor Progression and a Potential Therapeutic Target.
    Cancer Res. 2018 Oct 17. pii: 0008-5472.CAN-18-0345.
    PubMed     Text format     Abstract available


  14. LIU T, Xu H, Huang M, Ma W, et al
    Circulating glioma cells exhibit stem cell-like properties.
    Cancer Res. 2018 Oct 15. pii: 0008-5472.CAN-18-0650.
    PubMed     Text format     Abstract available


  15. EINO D, Tsukada Y, Naito H, Kanemura Y, et al
    LPA4-mediated vascular network formation increases the efficacy of anti-PD-1 therapy against brain tumors.
    Cancer Res. 2018 Oct 9. pii: 0008-5472.CAN-18-0498.
    PubMed     Text format     Abstract available


  16. BIRCH JL, Strathdee K, Gilmour L, Vallatos A, et al
    A novel small molecule inhibitor of MRCK prevents radiation-driven invasion in glioblastoma.
    Cancer Res. 2018 Oct 2. pii: 0008-5472.CAN-18-1697.
    PubMed     Text format     Abstract available


    August 2018
  17. GOUDARZI KM, Espinoza JA, Guo M, Bartek J, et al
    Reduced expression of PROX1 transitions glioblastoma cells into a mesenchymal gene expression subtype.
    Cancer Res. 2018 Aug 22. pii: 0008-5472.CAN-18-0320.
    PubMed     Text format     Abstract available


    July 2018
  18. MAIR R, Wright A, Ros S, Hu DE, et al
    Metabolic imaging detects low levels of glycolytic activity that vary with levels of c-Myc expression in patient-derived xenograft models of glioblastoma.
    Cancer Res. 2018 Jul 27. pii: 0008-5472.CAN-18-0759.
    PubMed     Text format     Abstract available


  19. XING F, Liu Y, Wu SY, Wu K, et al
    Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis.
    Cancer Res. 2018 Jul 19. pii: 0008-5472.CAN-18-1102.
    PubMed     Text format     Abstract available


  20. SINGH M, Venugopal C, Tokar T, McFarlane N, et al
    Therapeutic targeting of the pre-metastatic stage in human brain metastasis.
    Cancer Res. 2018 Jul 9. pii: 0008-5472.CAN-18-1022.
    PubMed     Text format     Abstract available


  21. CARRUTHERS RD, Ahmed SU, Ramachandran S, Strathdee K, et al
    Replication stress drives constitutive activation of the DNA damage response and radioresistance in glioblastoma stem-like cells.
    Cancer Res. 2018 Jul 5. pii: 0008-5472.CAN-18-0569.
    PubMed     Text format     Abstract available


  22. WANG R, Zhang S, Chen X, Li N, et al
    CircNT5E acts as a sponge of microRNA-422a to promote glioblastoma tumorigenesis.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-18-0532.
    PubMed     Text format     Abstract available


    June 2018
  23. QAZI MA, Vora P, Venugopal C, Adams J, et al
    Co-targeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma.
    Cancer Res. 2018 Jun 26. pii: 0008-5472.CAN-18-0267.
    PubMed     Text format     Abstract available


  24. LIANG L, Morrison LC, Tatari N, Stromecki M, et al
    CD271+ cells are diagnostic and prognostic and exhibit elevated MAPK activity in SHH medulloblastoma.
    Cancer Res. 2018 Jun 21. pii: 0008-5472.CAN-18-0027.
    PubMed     Text format     Abstract available


  25. LUOTO S, Hermelo I, Vuorinen EM, Hannus P, et al
    Computational characterization of suppressive immune microenvironments in glioblastoma.
    Cancer Res. 2018 Jun 19. pii: 0008-5472.CAN-17-3714.
    PubMed     Text format     Abstract available


  26. PALLAVICINI G, Sgro F, Garello F, Falcone M, et al
    Inactivation of citron kinase inhibits medulloblastoma progression by inducing apoptosis and cell senescence.
    Cancer Res. 2018 Jun 19. pii: 0008-5472.CAN-17-4060.
    PubMed     Text format     Abstract available


    May 2018
  27. OLMEZ I, Zhang Y, Manigat L, Benamar M, et al
    Combined c-Met/Trk inhibition overcomes resistance to CDK4/6 inhibitors in Glioblastoma.
    Cancer Res. 2018 May 29. pii: 0008-5472.CAN-17-3124.
    PubMed     Text format     Abstract available


  28. MILOUSHEV VZ, Granlund KL, Boltyanskiy R, Lyashchenko SK, et al
    Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients.
    Cancer Res. 2018 May 16. pii: 0008-5472.CAN-18-0221.
    PubMed     Text format     Abstract available


  29. PAL S, Kozono D, Yang X, Fendler W, et al
    Dual HDAC and PI3K inhibition abrogates NFkappaB- and FOXM1-mediated DNA damage response to radiosensitize pediatric high-grade gliomas.
    Cancer Res. 2018 May 14. pii: 0008-5472.CAN-17-3691.
    PubMed     Text format     Abstract available


  30. CHEN Z, Morales JE, Guerrero PA, Sun H, et al
    PTPN12/PTP-PEST Regulates Phosphorylation-Dependent Ubiquitination and Stability of Focal Adhesion Substrates in Invasive Glioblastoma Cells.
    Cancer Res. 2018 May 9. pii: 0008-5472.CAN-18-0085.
    PubMed     Text format     Abstract available


    April 2018
  31. LIU J, Sareddy GR, Zhou M, Viswanadhapalli S, et al
    Differential effects of estrogen receptor beta isoforms on glioblastoma progression.
    Cancer Res. 2018 Apr 16. pii: 0008-5472.CAN-17-3470.
    PubMed     Text format     Abstract available


  32. ORLANDO D, Miele E, De Angelis B, Guercio M, et al
    Adoptive immunotherapy using PRAME-specific T cells in medulloblastoma.
    Cancer Res. 2018 Apr 3. pii: 0008-5472.CAN-17-3140.
    PubMed     Text format     Abstract available


    March 2018
  33. REN D, Zhu X, Kong R, Zhao Z, et al
    Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.
    Cancer Res. 2018 Mar 22. pii: 0008-5472.CAN-17-2994.
    PubMed     Text format     Abstract available


  34. HALL AW, Battenhouse AM, Shivram H, Morris AR, et al
    Bivalent chromatin domains in glioblastoma reveal a subtype-specific signature of glioma stem cells.
    Cancer Res. 2018 Mar 16. pii: 0008-5472.CAN-17-1724.
    PubMed     Text format     Abstract available


  35. MUKHERJEE J, Johannessen TA, Ohba S, Chow TT, et al
    Mutant IDH1 cooperates with ATRX loss to drive the alternative lengthening of telomere (ALT) phenotype in glioma.
    Cancer Res. 2018 Mar 15. pii: 0008-5472.CAN-17-2269.
    PubMed     Text format     Abstract available


  36. SADAHIRO H, Kang KD, Gibson JT, Minata M, et al
    Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma.
    Cancer Res. 2018 Mar 12. pii: 0008-5472.CAN-17-2433.
    PubMed     Text format     Abstract available


    February 2018
  37. RIMKUS TK, Carpenter RL, Sirkisoon SR, Zhu D, et al
    Truncated glioma-associated oncogene homolog 1 (tGLI1) mediates mesenchymal glioblastoma via transcriptional activation of CD44.
    Cancer Res. 2018 Feb 20. pii: 0008-5472.CAN-17-2933.
    PubMed     Text format     Abstract available


  38. CHOI JS, Kim CS, Berdis A
    Inhibition of Translesion DNA Synthesis as a Novel Therapeutic Strategy to Treat Brain Cancer.
    Cancer Res. 2018;78:1083-1096.
    PubMed     Text format     Abstract available


  39. DELWAR ZM, Kuo Y, Wen YH, Rennie PS, et al
    Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3.
    Cancer Res. 2018;78:718-730.
    PubMed     Text format     Abstract available


    January 2018
  40. SANG Y, Li Y, Song L, Alvarez AA, et al
    TRIM59 promotes gliomagenesis by inhibiting TC45 dephosphorylation of STAT3.
    Cancer Res. 2018 Jan 31. pii: 0008-5472.CAN-17-2774.
    PubMed     Text format     Abstract available


  41. VISWANATH P, Radoul M, Izquierdo-Garcia JL, Ong WQ, et al
    2-hydroxyglutarate-mediated autophagy of the endoplasmic reticulum leads to an unusual downregulation of phospholipid biosynthesis in mutant IDH1 gliomas.
    Cancer Res. 2018 Jan 22. pii: 0008-5472.CAN-17-2926.
    PubMed     Text format     Abstract available


    December 2017
  42. XIAO W, Zhang R, Sohrabi A, Ehsanipour A, et al
    Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
    Cancer Res. 2017 Dec 27. pii: 0008-5472.CAN-17-2429.
    PubMed     Text format     Abstract available


  43. ZHANG Y, Wang T, Wang S, Xiong Y, et al
    Nkx2-2as suppression contributes to the pathogenesis of Sonic Hedgehog medulloblastoma.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-1631.
    PubMed     Text format     Abstract available


  44. WEISS T, Weller M, Guckenberger M, Sentman CL, et al
    NKG2D-based CAR-T cells and radiotherapy exert synergistic efficacy in glioblastoma.
    Cancer Res. 2017 Dec 8. pii: 0008-5472.CAN-17-1788.
    PubMed     Text format     Abstract available


  45. ZAKARIA R, Platt-Higgins A, Rathi N, Radon M, et al
    T cell densities in brain metastases are associated with patient survival times and diffusion tensor MRI changes.
    Cancer Res. 2017 Dec 6. pii: 0008-5472.CAN-17-1720.
    PubMed     Text format     Abstract available


    November 2017
  46. LV D, Jia F, Hou Y, Sang Y, et al
    Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding.
    Cancer Res. 2017;77:6190-6201.
    PubMed     Text format     Abstract available


  47. WAITKUS MS, Pirozzi CJ, Moure CJ, Diplas BH, et al
    Adaptive evolution of the GDH2 allosteric domain promotes gliomagenesis by resolving IDH1R132H induced metabolic liabilities.
    Cancer Res. 2017 Nov 2. pii: canres.1352.2017.
    PubMed     Text format     Abstract available


  48. MIYAUCHI JT, Caponegro MD, Chen D, Choi MK, et al
    Deletion of neuropilin 1 from microglia or bone marrow-derived macrophages slows glioma progression.
    Cancer Res. 2017 Nov 2. pii: canres.1435.2017.
    PubMed     Text format     Abstract available


  49. HOLLON TC, Lewis S, Pandian B, Niknafs YS, et al
    Rapid Intraoperative Diagnosis of Pediatric Brain Tumors Using Stimulated Raman Histology.
    Cancer Res. 2017 Nov 1. pii: canres.1974.2017.
    PubMed     Text format     Abstract available


  50. REAP E, Suryadevara CM, Batich KA, Sanchez-Perez L, et al
    Dendritic cells enhance polyfunctionality of adoptively transferred T cells which target cytomegalovirus in glioblastoma.
    Cancer Res. 2017 Nov 1. pii: canres.0469.2017.
    PubMed     Text format     Abstract available


  51. NORTON I, Essayed W, Zhang F, Pujol S, et al
    SlicerDMRI: Open Source Diffusion MRI Software for Brain Cancer Research.
    Cancer Res. 2017;77:e101-e103.
    PubMed     Text format     Abstract available


    October 2017
  52. LIU Y, Yuelling LW, Wang Y, Du F, et al
    Astrocytes promote medulloblastoma progression through hedgehog secretion.
    Cancer Res. 2017 Oct 6. pii: canres.1463.2017.
    PubMed     Text format     Abstract available


    September 2017
  53. YANG R, Chen LH, Hansen LJ, Carpenter AB, et al
    Cic loss promotes gliomagenesis via aberrant neural stem cell proliferation and differentiation.
    Cancer Res. 2017 Sep 22. pii: canres.1018.2017.
    PubMed     Text format     Abstract available


  54. STEPANOVA DS, Semenova G, Kuo YM, Andrews AJ, et al
    An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.
    Cancer Res. 2017;77:5026-5038.
    PubMed     Text format     Abstract available


    August 2017
  55. FIGUEROA J, Phillips LM, Shahar T, Hossain A, et al
    Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587.
    Cancer Res. 2017 Aug 30. pii: canres.2524.2016.
    PubMed     Text format     Abstract available


  56. LEE E, Pain M, Wang H, Herman JA, et al
    Sensitivity to BUB1B inhibition defines an alternative classification of glioblastoma.
    Cancer Res. 2017 Aug 30. pii: canres.0736.2017.
    PubMed     Text format     Abstract available


  57. CHOW KH, Park HJ, George J, Yamamoto K, et al
    S100A4 is a biomarker and regulator of glioma stem cells that is critical for mesenchymal transition in glioblastoma.
    Cancer Res. 2017 Aug 14. pii: canres.1294.2017.
    PubMed     Text format     Abstract available


  58. CHEN X, Ma H, Wang Z, Zhang S, et al
    EZH2 palmitoylation mediated by ZDHHC5 in p53 mutant glioma drives malignant development and progression.
    Cancer Res. 2017 Aug 3. pii: canres.1139.2017.
    PubMed     Text format     Abstract available


    July 2017
  59. YIN J, Oh YT, Kim JY, Kim SS, et al
    Transglutaminase 2 inhibition reverses mesenchymal transdifferentiation of glioma stem cells by regulating C/EBPbeta signaling.
    Cancer Res. 2017 Jul 28. pii: canres.0388.2017.
    PubMed     Text format     Abstract available


  60. WANG X, Huang Z, Wu Q, Prager BC, et al
    MYC-regulated Mevalonate Metabolism Maintains Brain Tumor Initiating Cells.
    Cancer Res. 2017 Jul 20. pii: canres.0114.2017.
    PubMed     Text format     Abstract available



  61. Correction: Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells.
    Cancer Res. 2017;77:3962.
    PubMed     Text format    


  62. JERMYN M, Mercier J, Aubertin K, Desroches J, et al
    Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy.
    Cancer Res. 2017;77:3942-3950.
    PubMed     Text format     Abstract available


  63. KURTSDOTTER I, Topcic D, Karlen A, Singla B, et al
    SOX5/6/21 prevent oncogene-driven transformation of brain stem cells.
    Cancer Res. 2017 Jul 7. pii: canres.0704.2017.
    PubMed     Text format     Abstract available


    May 2017
  64. YAN H, Romero-Lopez M, Benitez LI, Di K, et al
    3D mathematical modeling of glioblastoma suggests that transdifferentiated vascular endothelial cells mediate resistance to current standard-of-care therapy.
    Cancer Res. 2017 May 23. pii: canres.3094.2016.
    PubMed     Text format     Abstract available


  65. TECH K, Tikunov AP, Farooq H, Morrissy AS, et al
    Pyruvate kinase inhibits proliferation during postnatal cerebellar neurogenesis and suppresses medulloblastoma formation.
    Cancer Res. 2017 May 17. pii: canres.3304.2016.
    PubMed     Text format     Abstract available


  66. ZHANG Y, Cruickshanks N, Yuan F, Wang B, et al
    Targetable T-type calcium channels drive glioblastoma.
    Cancer Res. 2017 May 16. pii: canres.2347.2016.
    PubMed     Text format     Abstract available


  67. GRAUSAM KB, Dooyema SD, Bihannic L, Premathilake H, et al
    ATOH1 promotes leptomeningeal dissemination and metastasis of Sonic Hedgehog subgroup medulloblastomas.
    Cancer Res. 2017 May 10. pii: canres.1836.2016.
    PubMed     Text format     Abstract available


    April 2017
  68. SARKAR S, Mirzaei R, Zemp FJ, Wu W, et al
    Activation of NOTCH signaling by tenascin-C promotes growth of human brain tumor-initiating cells.
    Cancer Res. 2017 Apr 17. pii: canres.2171.2016.
    PubMed     Text format     Abstract available


  69. STEVENS LE, Cheung WKC, Adua SJ, Arnal-Estape A, et al
    Extracellular Matrix Receptor Expression in Subtypes of Lung Adenocarcinoma Potentiates Outgrowth of Micrometastases.
    Cancer Res. 2017;77:1905-1917.
    PubMed     Text format     Abstract available


  70. ZINNHARDT B, Pigeon H, Theze B, Viel T, et al
    Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake.
    Cancer Res. 2017;77:1831-1841.
    PubMed     Text format     Abstract available


  71. SCHNEPP PM, Lee DD, Guldner IH, O'Tighearnaigh TK, et al
    GAD1 Upregulation Programs Aggressive Features of Cancer Cell Metabolism in the Brain Metastatic Microenvironment.
    Cancer Res. 2017 Apr 11. pii: canres.2289.2016.
    PubMed     Text format     Abstract available


    February 2017
  72. CHEN Z, Feng X, Herting CJ, Alvarez Garcia V, et al
    Cellular and molecular identity of tumor-associated macrophages in glioblastoma.
    Cancer Res. 2017 Feb 24. pii: canres.2310.2016.
    PubMed     Text format     Abstract available


  73. LU Y, Kwintkiewicz J, Liu Y, Tech K, et al
    Chemosensitivity of IDH1 mutant gliomas due to an impairment in PARP1-mediated DNA repair.
    Cancer Res. 2017 Feb 15. pii: canres.2773.2016.
    PubMed     Text format     Abstract available


    January 2017
  74. KOSSATZ S, Carney B, Schweitzer ME, Carlucci G, et al
    Biomarker based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.
    Cancer Res. 2017 Jan 20. pii: canres.2850.2016.
    PubMed     Text format     Abstract available


  75. NIKLASSON M, Maddalo G, Sramkova Z, Mutlu E, et al
    Membrane-depolarizing channel blockers induce selective glioma cell death by impairing nutrient transport and unfolded protein/amino acid responses.
    Cancer Res. 2017 Jan 13. pii: canres.2274.2016.
    PubMed     Text format     Abstract available


    December 2016
  76. WARD SA, Warrington NM, Taylor S, Kfoury N, et al
    Reprogramming medulloblastoma-propagating cells via combined antagonism of Sonic Hedgehog and CXCR4.
    Cancer Res. 2016 Dec 28. pii: canres.0847.2016.
    PubMed     Text format     Abstract available


  77. BINDA E, Visioli A, Giani F, Trivieri N, et al
    Wnt5a drives an invasive phenotype in human glioblastoma stem-like cells.
    Cancer Res. 2016 Dec 23. pii: canres.1693.2016.
    PubMed     Text format     Abstract available



  78. Correction: IFN-beta Down-Regulates the Expression of DNA Repair Gene MGMT and Sensitizes Resistant Glioma Cells to Temozolomide.
    Cancer Res. 2016;76:7293.
    PubMed     Text format    


  79. WAHL DR, Dresser J, Wilder-Romans K, Parsels JD, et al
    Glioblastoma therapy can be augmented by targeting IDH1-mediated NADPH biosynthesis.
    Cancer Res. 2016 Dec 6. pii: canres.2008.2016.
    PubMed     Text format     Abstract available


    November 2016
  80. SREEDHARAN S, Maturi NP, Xie Y, Sundstrom A, et al
    Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype.
    Cancer Res. 2016 Nov 15. doi: 10.1158/0008-5472.CAN-16-2482.
    PubMed     Text format     Abstract available


  81. MITTAPALLI RK, Adkins CE, Bohn KA, Mohammad AS, et al
    Quantitative Fluorescent Microscopy to Measure Vascular Pore Sizes in Primary and Metastatic Brain Tumors.
    Cancer Res. 2016 Nov 4. pii: canres.1711.2016.
    PubMed     Text format     Abstract available


  82. ZHU G, Rankin SL, Larson JD, Zhu X, et al
    PTEN signaling in the postnatal perivascular progenitor niche drives medulloblastoma formation.
    Cancer Res. 2016 Nov 4. pii: canres.1991.2016.
    PubMed     Text format     Abstract available


    October 2016
  83. NAGEL ZD, Kitange GJ, Gupta SK, Joughin BA, et al
    DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme.
    Cancer Res. 2016 Oct 28. pii: canres.1151.2016.
    PubMed     Text format     Abstract available


    September 2016
  84. KAUR A, Denisova O, Qiao X, Jumppanen M, et al
    PP2A inhibitor PME-1 drives kinase inhibitor resistance in glioma cells.
    Cancer Res. 2016 Sep 26. pii: canres.1134.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: